Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

If you’re taking finasteride — or the brand name versions Propecia or Proscar — you’re probably checking your hairline for ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

New data suggest that current recommendations overstate the proportion of patients who would receive significant kidney ...

Vanderbilt University has identified leucine-rich repeat kinase 2 (LRRK2; dardarin) and LRRK2 (G2019S mutant) inhibitors reported to be useful for the treatment of tauopathies, cancer, Crohn’s disease ...

Researchers at West Virginia University are advancing pancreatic cancer treatment by targeting a specific enzyme, ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

CK Regeon Inc. has divulged indirubin derivatives acting as CXXC-type zinc finger protein 5 (CXXC5)/DVL interaction inhibitors reported to be useful for the treatment of skin lesions, wounds, ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...